|
|
|
201-500 employees
View all
|
|
pharmaceuticals
|
|
500 Boylston St,Boston,Massachusetts,US
|
|
Cerevel Therapeutics is a biopharmaceutical company focused on developing new therapies to treat disorders of the central nervous system (CNS). The company has a portfolio of experimental neuroscience therapies, which include three clinical-stage compounds and several pre-clinical compounds designed to target a broad range of CNS disorders, including Parkinson’s, Alzheimer’s, epilepsy, schizophrenia and addiction. Headquartered in the Greater Boston area, Cerevel was formed in 2018 through a partnership between Bain Capital and Pfizer.
|
Cerevel Therapeutics Email Formats | Example Email Formats | Percentage |
---|---|---|
{first}.{last} | [email protected] |
66.67%
|
The widely used Cerevel Therapeutics email format is {first}.{last} (e.g. [email protected]) with 66.67% adoption across the company.
To contact Cerevel Therapeutics customer service number in your country click here to find.
Daniela Vincent is the CEO of Cerevel Therapeutics. To contact Daniela Vincent email at [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.